0.79
price down icon7.06%   -0.06
after-market Dopo l'orario di chiusura: .79
loading
Precedente Chiudi:
$0.85
Aprire:
$0.86
Volume 24 ore:
346.16K
Relative Volume:
0.56
Capitalizzazione di mercato:
$43.85M
Reddito:
$2.91M
Utile/perdita netta:
$-15.61M
Rapporto P/E:
-2.0573
EPS:
-0.384
Flusso di cassa netto:
$-14.50M
1 W Prestazione:
+1.28%
1M Prestazione:
+30.13%
6M Prestazione:
-33.61%
1 anno Prestazione:
+3.93%
Intervallo 1D:
Value
$0.7805
$0.8607
Intervallo di 1 settimana:
Value
$0.72
$0.90
Portata 52W:
Value
$0.48
$1.57

Icecure Medical Ltd Stock (ICCM) Company Profile

Name
Nome
Icecure Medical Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
64
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ICCM's Discussions on Twitter

Icecure Medical Ltd Borsa (ICCM) Ultime notizie

pulisher
Oct 31, 2024

IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023 - BioSpace

Oct 31, 2024
pulisher
Oct 29, 2024

Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

Independent Study Results in Japan Demonstrate Zero (0%) Breast - GuruFocus.com

Oct 29, 2024
pulisher
Oct 23, 2024

IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024 - GuruFocus.com

Oct 23, 2024
pulisher
Oct 23, 2024

Globus Medical (NYSE:GMED) & IceCure Medical (NASDAQ:ICCM) Head-To-Head Contrast - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

IceCure receives US patent allowance for cryoablation system - Investing.com

Oct 22, 2024
pulisher
Oct 21, 2024

IceCure receives US patent allowance for cryoablation system By Investing.com - Investing.com Australia

Oct 21, 2024
pulisher
Oct 21, 2024

IceCure Announces FDA Advisory Panel Meeting Date for Marketing - GuruFocus.com

Oct 21, 2024
pulisher
Oct 21, 2024

IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System - Marketscreener.com

Oct 21, 2024
pulisher
Oct 15, 2024

Analytical Overview: Icecure Medical Ltd (ICCM)’s Ratios Tell a Financial Story - The Dwinnex

Oct 15, 2024
pulisher
Oct 11, 2024

IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablati - GuruFocus.com

Oct 11, 2024
pulisher
Oct 08, 2024

Icecure Medical Ltd (ICCM) shows promising results - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Ratios in Focus: Analyzing Icecure Medical Ltd (ICCM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 08, 2024
pulisher
Oct 07, 2024

IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference - StreetInsider.com

Oct 07, 2024
pulisher
Oct 03, 2024

Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic - Yahoo Finance

Oct 03, 2024
pulisher
Sep 25, 2024

IceCure reports high success rate in breast cancer trial By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 25, 2024

Ex-ad industry employees launch a new digital agency 'itch' - afaqs!

Sep 25, 2024
pulisher
Sep 24, 2024

IceCure reports high success rate in breast cancer trial - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

Why Is Interactive Strength Stock Surging Today? - Benzinga

Sep 24, 2024
pulisher
Sep 24, 2024

InCred's Aditya Sood Reveals Key Factors Behind Selecting Indraprastha Medical From Hospital Sector - Business Today

Sep 24, 2024
pulisher
Sep 24, 2024

IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96 - StreetInsider.com

Sep 24, 2024
pulisher
Sep 24, 2024

IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate - PR Newswire

Sep 24, 2024
pulisher
Sep 20, 2024

The time has not yet come to remove your chips from the table: Icecure Medical Ltd (ICCM) - SETE News

Sep 20, 2024
pulisher
Sep 18, 2024

What will the future hold for Icecure Medical Ltd (NASDAQ:ICCM) stock? - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

FDA AdComm to discuss IceCure's ProSense on Nov. 7 - MSN

Sep 18, 2024
pulisher
Sep 16, 2024

Study: Liquid Nitrogen-Based Cryoablation Safe for Treating Treating Tumors of the Lung, Bone and Soft Tissues - Imaging Technology News

Sep 16, 2024
pulisher
Sep 16, 2024

Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues - StockTitan

Sep 16, 2024
pulisher
Sep 14, 2024

H.C. Wainwright maintains Buy rating on IceCure Medical stock By Investing.com - Investing.com Canada

Sep 14, 2024
pulisher
Sep 13, 2024

H.C. Wainwright maintains Buy rating on IceCure Medical stock - Investing.com India

Sep 13, 2024
pulisher
Sep 13, 2024

Icecure Medical Ltd (ICCM) deserves closer scrutiny - US Post News

Sep 13, 2024
pulisher
Sep 12, 2024

IceCure seeks FDA nod for breast cancer treatment - Investing.com

Sep 12, 2024
pulisher
Sep 12, 2024

IceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024 - PR Newswire

Sep 12, 2024
pulisher
Sep 04, 2024

IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences - PR Newswire

Sep 04, 2024
pulisher
Sep 02, 2024

Icecure Medical Ltd (ICCM) can make a big difference with a little luck - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Icecure Medical Ltd (ICCM) produces promising results - US Post News

Sep 02, 2024
pulisher
Aug 28, 2024

USPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation Technologies - The Malaysian Reserve

Aug 28, 2024
pulisher
Aug 28, 2024

IceCure expands patent portfolio with USPTO allowance - Investing.com

Aug 28, 2024
pulisher
Aug 28, 2024

IceCure Medical Strengthens Patent Portfolio - TipRanks

Aug 28, 2024
pulisher
Aug 21, 2024

IceCure Medical stock target cut, retains buy rating on Q2 results - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

IceCure Medical stock target cut, retains buy rating on Q2 results By Investing.com - Investing.com South Africa

Aug 21, 2024
pulisher
Aug 21, 2024

IceCure Medical Ltd (NASDAQ:ICCM) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 21, 2024
pulisher
Aug 21, 2024

Earnings call: IceCure Medical reports growth and upcoming FDA panel - Investing.com India

Aug 21, 2024
pulisher
Aug 20, 2024

Earnings call: IceCure Medical reports growth and upcoming FDA panel By Investing.com - Investing.com Australia

Aug 20, 2024
pulisher
Aug 20, 2024

IceCure Medical Ltd. (ICCM) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 20, 2024
pulisher
Aug 20, 2024

IceCure Medical Reports 20% Growth in ProSense® System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global Markets - The Malaysian Reserve

Aug 20, 2024
pulisher
Aug 20, 2024

IceCure Medical to Report Second Quarter 2024 Financial & Operational Results on August 20, 2024 - PR Newswire

Aug 20, 2024

Icecure Medical Ltd Azioni (ICCM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$108.92
price up icon 0.47%
medical_devices STE
$227.44
price up icon 0.72%
medical_devices PHG
$27.08
price up icon 0.00%
$69.00
price down icon 1.00%
$88.17
price up icon 1.36%
medical_devices EW
$66.69
price up icon 0.33%
Capitalizzazione:     |  Volume (24 ore):